Eskalith-CR Interactions
There are 723 drugs known to interact with Eskalith-CR (lithium), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 185 are major, 501 are moderate, and 37 are minor.
- View all 723 medications that may interact with Eskalith-CR
- View Eskalith-CR alcohol/food interactions (1)
- View Eskalith-CR disease interactions (12)
Most frequently checked interactions
View interaction reports for Eskalith-CR (lithium) and the medicines listed below.
- Abilify (aripiprazole)
- Aciphex (rabeprazole)
- albuterol
- amlodipine
- aripiprazole
- baclofen
- Celexa (citalopram)
- clonazepam
- Colace (docusate)
- Cymbalta (duloxetine)
- doxycycline
- Euthyrox (levothyroxine)
- gabapentin
- hydrochlorothiazide
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- lamotrigine
- Latuda (lurasidone)
- levothyroxine
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- melatonin
- propranolol
- Seroquel (quetiapine)
- Synthroid (levothyroxine)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
- Zyprexa (olanzapine)
Eskalith-CR alcohol/food interactions
There is 1 alcohol/food interaction with Eskalith-CR (lithium).
Eskalith-CR disease interactions
There are 12 disease interactions with Eskalith-CR (lithium) which include:
- dementia
- cardiac disease
- dehydration
- diarrhea/hyperhidrosis
- hypothyroidism
- renal dysfunction
- sodium depletion
- previous neuroleptic malignant syndrome (NMS)
- seizure disorders
- fever
- hyperprolactinemia/breast cancer
- neutropenia
Report options
QR code containing a link to this page
More about Eskalith-CR (lithium)
- Eskalith-CR consumer information
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimanic agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
